peripheral facial paralysis
Recently Published Documents


TOTAL DOCUMENTS

230
(FIVE YEARS 68)

H-INDEX

13
(FIVE YEARS 1)

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Zelin Yu ◽  
Mengxia Shen ◽  
Wenfang Shang ◽  
Jiangxia Wu ◽  
Lihua Xuan

Objective. Investigate the optimum time of acupuncture treatment in peripheral facial paralysis in order to provide evidence for clinical treatment. Methods. CNKI, Wanfang, PubMed, Cochrane Library, and EMBASE databases were systematically searched from the inception dates to February 20, 2020. Studies limited to participants with acute peripheral facial paralysis treated with acupuncture and patients without information of the stage were excluded. The primary outcomes were effective rate and cure rate (based on facial nerve function scores). This meta-analysis is registered with PROSPERO, number CRD42020169870. Results. 15 randomized controlled trials that enrolled 2847 participants met the selection criteria. There was no significant differences in the effective rate (RR, 1.22; 95% CI, 0.70-2.11) when comparing acupuncture to prednisone therapy in acute facial paralysis. Acupuncture treatment in the acute stage increased both the effective rate (RR, 1.03; 95% CI, 1.00-1.07) and the cure rate (RR, 1.34; 95% CI, 1.14-1.58) compared to that in the nonacute stage. Conclusions. In this meta-analysis, acupuncture showed a better effect in the acute stage than the nonacute stage for participants with peripheral facial paralysis. There was no statistical difference in the effective rate no matter the choice of acupuncture or prednisone therapies in the acute stage. These findings encourage early acupuncture treatment in peripheral facial paralysis.


Medicine ◽  
2021 ◽  
Vol 100 (49) ◽  
pp. e27769
Author(s):  
Jingyun Ji ◽  
Yuchen Liu ◽  
Weijie Wen ◽  
Fengyi Wang ◽  
Rundong Tang

Medicine ◽  
2021 ◽  
Vol 100 (46) ◽  
pp. e27680
Author(s):  
Fengyi Wang ◽  
Qinglin Li ◽  
Qiaoyun Yu ◽  
Junquan Liang ◽  
Yunxiang Xu ◽  
...  

2021 ◽  
pp. 014556132110565
Author(s):  
Bo Yang ◽  
Fang Zhang ◽  
Ying Tian ◽  
Huijun Yang

Non-iatrogenic traumatic facial paralysis is most common in intratemporal facial nerve injury caused by temporal bone fracture, followed by intraparotid facial nerve branch injury. Facial paralysis caused by injury to the extratemporal trunk of the facial nerve is extremely rare. We present a case of a 60-year-old man suffering from immediate complete left peripheral facial paralysis due to blunt transection of extratemporal trunk of facial nerve by stabbing with a car key. There was a facial nerve defect about 1 cm in length. The great auricular nerve was grafted to repair the facial nerve. Over 12 months, his facial nerve function improved to a House–Brackmann III/VI.


Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Binyan Yu ◽  
Lihua Xuan ◽  
Yutong Jin ◽  
Shan Chen ◽  
Shan Liu ◽  
...  

Abstract Background Facial expression muscles atrophy is one kind of sequelae after peripheral facial paralysis. It causes critical problems in facial appearance of patient as well as social and psychological problems. This study aims to evaluate the efficacy and safety of Thread-embedding acupuncture (TEA) for the management of facial expression muscles atrophy after peripheral facial paralysis. Methods This is a patient-assessor blinded, randomized, sham-controlled trial. A total of fifty-six eligible patients will be randomly divided into TEA (n=28) and sham TEA (STEA) (n=28) groups. Both groups will receive TEA or STEA treatment at the frontal muscle and the depressor anguli oris muscle, at one predefined points once a week for eight weeks. Additionally, both groups will receive traditional acupuncture treatment at ten acupoints (GB20, LI4, LR3, GB12, ST7, SI18, LI20, BL2, SJ23, ST4) twice a week for eight weeks as a concurrent treatment. B-mode ultrasonography will be used to assess the changes in facial expression muscle thickness ratio of the affected/healthy side at baseline and at 10 weeks after screening, as the primary outcome. House-Brackmann Grade and lip mobility score will be measured and analyzed at baseline and 4, 8, 10, and 12 weeks after screening, as secondary outcomes. Discussion The study will compare TEA with sham TEA to explore the feasibility for TEA in improving facial expression muscles atrophy after peripheral facial paralysis. Trial registration Chinese Clinical Trial Registry, ChiCTR1900027170. Registered on 3 November 2019, http://www.chictr.org.cn/edit.aspx?pid=45173&htm=4


2021 ◽  
Vol 23 (2) ◽  
pp. 121-125
Author(s):  
Baul Kim ◽  
Soo-Im Jang ◽  
Soo-Hyun Park ◽  
Nam-Hee Kim

Bell’s palsy is an acute peripheral facial paralysis with no detectable cause. Although the prognosis of Bell’s palsy is generally good, some patients experience poor recoveries and there is no established treatment for those that do not recover even after receiving the conventional treatment. Here we present two cases of refractory Bell’s palsy with facial nerve enhancement in magnetic resonance imaging who showed symptomatic improvement after the late administration of high-dose intravenous methylprednisolone.


Sign in / Sign up

Export Citation Format

Share Document